MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $1.24 | Prev. Close $1.24 | Circuit Range N/A |
Day Range $1.19 - $1.27 | Year Range $0.65 - $2.37 | Volume 78,936 |
Average Traded $1.22 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $1.33 | $1.24 | -8.49% |
16-Jul-26 | $1.43 | $1.35 | -4.91% |
15-Jul-26 | $1.43 | $1.43 | +1.06% |
14-Jul-26 | $1.37 | $1.41 | +1.44% |
13-Jul-26 | $1.30 | $1.39 | +4.51% |
10-Jul-26 | $1.29 | $1.33 | +3.91% |
09-Jul-26 | $1.27 | $1.28 | +0.00% |